Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Actinomycin-D vs Multi-day Methotrexate in Low-Risk GTN
NCT01535053Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2012
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of methotrexate in gestational trophoblastic neoplasia (GTN), sponsored by GOG Foundation. Started Jun 2012; status: completed.
02
Drugs
methotrexate
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT01535053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535053.